

Five-year timeline for Brenntag SE (BNR.XETRA): major events, developments and context behind the stock's recent history.
View full stock analysis →2026 August — Q2 2026 results and guidance raise
Brenntag reported strong Q2 2026 results and raised full-year operating EBITDA guidance to EUR 1,350–1,450 million. Q2 2026 sales reached EUR 4.3 billion with operating gross profit of EUR 1,146 million, up 19 percent year-over-year. Operating EBITDA came in at EUR 463 million, a 41 percent increase year-over-year. For the first half of 2026, operating EBITDA totalled EUR 770 million and free cash flow was EUR 97 million. Investor sentiment shifted more positive as management highlighted structural improvements including margin expansion and cost savings alongside favourable pricing dynamics. The narrative moved from recovery and reshaping toward operational leverage and margin restoration [8][13][12].
2026 March — Annual Report 2025 and governance
The Annual Report 2025 was published confirming the integrated two-division model (Essentials and Specialties) and formalising leadership changes, including the CEO appointment effective September 1, 2025. The Supervisory Board supported a dividend proposal of EUR 1.90 per dividend-bearing share for the reporting period. The company emphasized strategic clarity around the two-division structure and returned to a narrative of disciplined execution and capital allocation, helping restore investor confidence after earlier restructuring and margin pressure [5][10].
2025 September — CEO succession
Jens Birgersson succeeded Dr. Christian Kohlpaintner as CEO effective September 1, 2025. The Supervisory Board had resolved the appointment in May 2025 and terminated the prior CEO's contract effective August 31, 2025. Market perception treated the change as a pivotal operational and strategic reset, with management continuity on the integrated model but fresh leadership expected to accelerate margin improvement, cost-out programmes and M&A integration discipline [5].
2025 June through December — Bolt-on acquisitions and selective M&A
Brenntag announced a series of bolt-on acquisitions to strengthen blending and mixing, logistics and regional footprint. Gefahrstoffzentrum (GSZ) Kaiserslautern was announced on June 26, 2025, and Airedale Group on December 16, 2025. Investors saw the M&A activity as execution of a stated strategy to grow specialties and value-added services, supporting diversification away from low-margin commodity distribution toward higher-margin specialties and services [3][4].
2024 — Multiple targeted acquisitions
Acquisitions closed in 2024 included Solventis Group (glycols and solvents, closed June 2024), Química Delta (Mexico, closed October 2024), Lawrence Industries (UK, closed March 2024), and the ICC site in Denver (July 2024). The market narrative focused on inorganic growth to build scale in material science, regional logistics and solvent/glycol capabilities. Investors treated these deals as engineering of the portfolio toward higher-margin segments and improved regional service networks [6][7].
2024 March — Russia and Belarus operations halted
Brenntag's financial statements reiterated the halting of all business operations in Russia and Belarus, a decision originally made in 2022. The market interpreted the decision as necessary risk management; it constrained revenue from those regions but avoided reputational and legal risks and formed part of broader geopolitical risk disclosures shaping investor assessment of geographic exposure [6].
2023 July — Governance restructure and divisional leadership
Brenntag redesigned its Management Board and governance to a two-division model (Essentials and Specialties) effective August 1, 2023. Ewout van Jarwaarde was appointed CEO Brenntag Essentials while Michael Friede continued as CEO Brenntag Specialties. Investors took this as a structural clarification intended to sharpen commercial focus, create clearer accountability between high-volume essentials and higher-margin specialties, and support targeted M&A. The narrative shifted to a portfolio management and specialization story [14].
2023 March — Acquisitions to expand specialties
Brenntag acquired Aik Moh Group on March 22, 2023, to expand industrial chemicals and value-added services in Southeast Asia. Other specialty deals followed through 2023, including Shanghai Saifu Chemical in China and various regional distribution deals. The company's M&A programme reinforced a narrative of building a global specialty platform with local execution. Investors viewed the deals as consistent with management's growth-through-acquisition strategy and potential margin uplift over time [3][9][15].
2022 March — Entry into Israel
Brenntag acquired Y.S. Ashkenazi Agencies Ltd in Israel and other targeted tuck-in deals. Continued execution of international expansion and tuck-in acquisitions reassured investors that organic growth would be complemented by M&A to fill regional gaps and specialty capabilities [3].
2021 January through August — North American acquisitions
Acquisitions in 2021 included Alpha Chemical (Canada, signed January 4, 2021) and Matrix Chemical (North American acetone specialist, announced August 4, 2021), plus other targeted buys to expand specialty food ingredients and distribution capacity. Matrix Chemical was described as the largest distributor of acetone in North America with approximately USD 200 million year-to-date sales in 2021. Early-period post-pandemic strategy emphasized consolidating distribution networks and acquiring specialty and product capabilities. The market viewed Brenntag as pursuing scale and vertical capabilities to protect margins versus pure commodity exposure [3].
2021 — Pandemic and supply-chain volatility
The 2020–2021 period showed pandemic-related volume and supply-chain volatility. Brenntag prioritized operational resilience, inventory and logistic management, and continued M&A where strategic. Investors balanced recognition of a cyclical demand rebound with concern about margin pressure from supply-chain costs and commodity price swings. Brenntag's M&A and diversification strategy was presented as a hedge against pure commodity cyclicality [7][3].
Receive hand-picked stock recommendations with detailed analyses every week
Start Free Trial